Innovative Products for Pediatric Patients

In the Branded Pharmaceutical market, Tris is focused on developing innovative products in the Pediatric space, specializing initially in Central Nervous System (CNS) products where our goal is to deliver meaningful patient benefits and develop strong intellectual property positions.

Starting with our initial branded product, DYANAVEL XR, Tris’ strategy is to apply our proprietary drug delivery technology to develop drug candidates to meet unmet medical needs for the underserved pediatric population. Our strategic initiatives for growth include continuing our internal R&D focus on CNS products by building a strong pipeline. 

Approved Products

Please see Important Safety Information, including Boxed WARNING for abuse and dependence, and Full Prescribing Information.